WeeklyMD

?

Channel Reputation Rank

#1390
?

Activity Status

Alive

last updated

According to the data and stats that were collected, 'WeeklyMD' channel has a mediocre rank. The channel mostly uses long articles along with sentence constructions of the intermediate readability level, which is a result that may indicate difficult texts on the channel, probably due to a big amount of industrial or scientific terms.

About 'WeeklyMD' Channel

A Health Information Site

? Updates History Monthly Yearly
? Content Ratio
? Average Article Length

Long articles are widely used on 'WeeklyMD' as elaborated and interesting content can help the channel to reach a high number of subscribers. In addition there are a few medium length articles.

short

long

? Readability Level

Intermediate readability level is common for 'WeeklyMD' articles as it addresses the matters that demand certain level of education to be understood. Sometimes the channel gets even more difficult by issuing pieces of advanced readability level (there are just a few of them). In addition the channel contains some materials of a basic readability level.

advanced

basic

? Sentiment Analysis

Negative aspect tends to prevail throughout the texts on the channel: that usually indicates a big amount of critical judgments and negatively biased opinion expressions (e.g. there may be some foul language or curse words contributing into a negative score).However, there are also some articles with a comparably favourable attitude and they make up more than one third of all the channel’s content.

positive

negative

Recent News

Unfortunately WeeklyMD has no news yet.

But you may check out related channels listed below.

Blood Pressure Meds Lower Heart, Stroke Risks in Diabetics: Analysis

[...] , Rahimi said, and this can lead to health problems. It’s clear that lowering high blood pressure is good for diabetics, Rahimi said, but it’s less certain whether patients “whose blood [...]

New Drug May Slow Recurrent Thyroid Cancer, Study Finds

[...] that received lenvatinib experienced some type of reaction while on the medication. High blood pressure was the most common side effect, occurring in two out of three patients who had a reaction [...]

Heart Drug Clears Up ‘Strawberry’ Birthmarks

[...] of infantile hemangioma in 2014. The drug — a so-called beta-blocker used to treat high blood pressure and angina — works by starving the hemangioma of blood. This stops its growth, and [...]

Donor Hearts Going to Waste, Researchers Report

[...] donor hearts were small size, advanced age and medical problems of donors, such as high blood pressure and diabetes. “However, when we look closely at the data, we find that most of these hearts [...]

Achilles Tendon Can Handle Downhill Running: Study

[...] and include it in normal training and racing,” study author Katy Andrews Neves said in a university news release. “Though there are greater forces placed on your body during downhill running, the [...]

Sleep Group Updates Shuteye Guidelines

[...] physiology of Loyola University Chicago Stritch School of Medicine, said in a university news release. “We know it’s restorative and important for memory consolidation. But we don’t [...]

Seasonal Flu Vaccine May Protect Against Deadly Bird Flu

[...] Wilson, an associate professor of medicine at the University of Chicago, said in a university news release. “We now need to develop ways of amplifying this response,” he added. The researchers [...]

First ‘Epigenomes’ Map Highlights How Genes Spur Health, Disease

[...] Joseph Costello, of the University of California, San Francisco, explained in a university news release. He said that epigenomic factors effectively “allow cells carrying the same DNA to [...]

FDA Approves Drug for Advanced Thyroid Cancer

[...] ) — The U.S. Food and Drug Administration on Friday approved a new drug to treat progressive thyroid cancer that continues to worsen despite radioactive iodine therapy. Results of a just-published [...]

Lenvima Approved for Common Thyroid Cancer

[...] ) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer (DTC) that has progressed despite radioactive iodine therapy, the agency said Friday in a [...]

New Drug May Slow Recurrent Thyroid Cancer, Study Finds

[...] THURSDAY, Feb. 12, 2015 (HealthDay News) — A new thyroid cancer drug can delay the progression of the disease almost five times longer than a placebo in [...]

Graphic Images on Cigarette Labels Affect Smokers’ Brains: Study

[...] appeals court ruled that graphic cigarette warning labels mandated by the U.S. Food and Drug Administration were unconstitutional. One reason was that the court felt the FDA didn’t have enough [...]

Newer Blood Thinner Beats Heparin for Certain Heart Attacks

[...] events,” she said. Fondaparinux already has been approved by the U.S. Food and Drug Administration for use in treating blood clots deep in the veins of the legs (deep vein thrombosis) [...]

Problems Spotted in Clinical Trials Can Go Unreported, Study Says

[...] MONDAY, Feb. 9, 2015 (HealthDay News) — Medical journals and the U.S. Food and Drug Administration rarely report violations of scientific conduct that federal regulators unearth during spot [...]

Milk Lurks in Some Dark Chocolate, Posing Allergy Risk: FDA

[...] danger for those allergic to dairy products. A new study conducted by the U.S. Food and Drug Administration revealed that many dark chocolate products contained milk, but didn’t say so on their [...]

Don’t Exclude Cancer Survivors From Lung Cancer Trials, Study Urges

[...] cancers. Those who had survived an earlier cancer had 10 percent better overall survival and 20 percent better lung cancer-specific survival than those who had never been [...]

New Drug May Slow Recurrent Thyroid Cancer, Study Finds

[...] disease,” Sherman said. The clinical trial did not observe any improvement in overall survival due to lenvatinib. However, Masters believes that the drug can’t help but improve [...]

FDA Approves Drug for Advanced Thyroid Cancer

[...] of life will need to be weighed, as well as the drug’s as-yet-unknown effect on overall survival, said Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer [...]

Cancer Patients Rarely Request Unneeded Tests, Treatments: Study

[...] these days is something quite different,” Back concluded. More information The U.S. National Cancer Institute has more about cancer. [...]

Don’t Exclude Cancer Survivors From Lung Cancer Trials, Study Urges

[...] Center in Dallas concluded. The study was published recently in the Journal of the National Cancer Institute. “When it comes to clinical trial eligibility, a history of prior cancer should not [...]

Lenvima Approved for Common Thyroid Cancer

[...] with thyroid cancer in 2014 and about 1,890 died from it, according to the U.S. National Cancer Institute. The thyroid gland is in the neck and helps regulate the body’s metabolism. Lenvima is [...]

New Drug May Slow Recurrent Thyroid Cancer, Study Finds

[...] .” More information For more information on targeted cancer therapies, visit the U.S. National Cancer Institute. [...]

FDA Approves Drug for Advanced Thyroid Cancer

[...] Center in Houston. Speaking in a center news release, Sherman said more than half of thyroid cancer patients do not respond to radioactive iodine treatment. In addition, thyroid cancers tend to [...]

New Drug May Slow Recurrent Thyroid Cancer, Study Finds

[...] survival, there was also a 65 percent response rate — almost unprecedented results for thyroid cancer patients with such advanced disease,” Sherman said. The clinical trial did not observe any [...]

?Key Phrases
Blood Pressure Meds Lower Heart, Stroke Risks in Diabetics: Analysis

[...] , Rahimi said, and this can lead to health problems. It’s clear that lowering high blood pressure is good for diabetics, Rahimi said, but it’s less certain whether patients “whose blood [...]

New Drug May Slow Recurrent Thyroid Cancer, Study Finds

[...] that received lenvatinib experienced some type of reaction while on the medication. High blood pressure was the most common side effect, occurring in two out of three patients who had a reaction [...]

Heart Drug Clears Up ‘Strawberry’ Birthmarks

[...] of infantile hemangioma in 2014. The drug — a so-called beta-blocker used to treat high blood pressure and angina — works by starving the hemangioma of blood. This stops its growth, and [...]

Donor Hearts Going to Waste, Researchers Report

[...] donor hearts were small size, advanced age and medical problems of donors, such as high blood pressure and diabetes. “However, when we look closely at the data, we find that most of these hearts [...]

Related channels